Machine learning
The company uses AI and ML to assist biopharma companies with clinical trials and will use the funds to expand its precision medicine and clinical development tools.
This follows the clearance for heart rate measurement on the FaceHeart mobile app in 2023.
Claimed to be a world's first, the LLM-driven model has demonstrated over 90% accuracy.
AI models have demonstrated up to 96.9% accuracy in screening ADHD, according to the Yonsei University study.
Also, Cureskin from India has launched an AI-powered hair analysis feature on its mobile application.
The Health Tech Investment Act would establish a reimbursement pathway for FDA-cleared AI-enabled medical devices.
Developed using a corpus of 38 million clinical texts, the open-source model scored 86% in the Korean Medical Licensing Examination.
Also, South Korean medical AI companies JLK and Coreline Soft announced recent regulatory approvals in Japan and the United States.
Developers at the Chinese University of Hong Kong claim it "communicates like a real doctor."
Also, two Korean digital dentistry solutions providers are integrating AI into their dental diagnostic software.